drugset / Trial / NCT02029430
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
RandomizedSingle-groupOpen-labelTreatment
Summary
This is a pilot study to determine the efficacy, kinetics and safety of aldoxorubicin in HIV positive subjects with Kaposi's sarcoma.
Timeline
- Start
- 2014-04-03
- Primary completion
- 2016-04-25
- Completion
- 2016-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aldoxorubicin | Small molecule | 50 mg/m2 | — |
| Subject | Aldoxorubicin | Small molecule | 100 mg/m2 | — |
| Subject | Aldoxorubicin | Small molecule | 150 mg/m2 | — |